by | Jan 25, 2021 | Basore, Katherine, Diamond, Michael, Fremont, Daved, Kafai, Natasha, Kim, Arthur, Ma, Hongming, Thackray, Larissa
— Disease indication – Venezuelan equine encephalitis virus (VEEV) infection, either naturally-arising and as a result of bioterrorism
Drug format – Biologic (soluble receptor fusion protein)
Drug class – First-in-class
Mode of action – This soluble fusion protein contains domain …
by | Jan 12, 2021 | Lodhi, Irfan, Semenkovich, Clay
— C57BL/6 ES cells were targeted with a vector (European Conditional Mouse Mutagenesis Program) carrying loxP sites flanking exon 3 of mouse Cept1. A karyotypically normal clone (of 10 correctly targeted) was injected into B6(Cg)-Tyrc-2J/J blastocysts and chimeric mice were bred with B6(Cg)-Tyrc2J/J f…
by | Jan 12, 2021 | Kumar, Sandeep, Peterson, Timothy
— These cells are K562 cells that express ACE2 (the receptor for SARS-CoV-2) from the endogenous locus and not a transgene.
by | Jan 12, 2021 | Colonna, Marco
— Mouse strain deficient in IL-34 production with defective Langerhans cells and microglia. These mice can be used to assess the role of the cytokine IL-34 in the development and maintenance of peripheral macrophage populations.
Publication: Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossin…
by | Jan 12, 2021 | Lenschow, Deborah
— This is a recombinant clone of the Chikungunya LR2006 virus expressing Cre recombinase inserted downstream of a subgenomic promoter. In vitro transcription and transfection of RNA derived from this plasmid into cells will result in the generation of Chikungunya virus that expresses Cre recombinase i…